chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Dysuria, Headache
Clinical narrative: Urinating more than usual; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (Urinating more than usual) and HEADACHE (Headache) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced DYSURIA (Urinating more than usual) and HEADACHE (Headache). At the time of the report, DYSURIA (Urinating more than usual) and HEADACHE (Headache) outcome was unknown.            Concomitant medications were not reported. Treatment information was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Action taken with the mRNA-1273 in response to the event is not applicable.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever 101.2; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 101.2) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 29-Jan-2021, the patient experienced PYREXIA (Fever 101.2). At the time of the report, PYREXIA (Fever 101.2) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, Body temperature: 101.2 (High) 101.2F.         No concomitant medications or treatment details reported.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Chills, Fatigue
Clinical narrative: severe arm pain; Tiredness; no energy; fever; chills; body aches; joint aches (hip and neck); not sleeping at night; arm swelled up; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), INSOMNIA (not sleeping at night), PYREXIA (fever), CHILLS (chills) and PAIN (body aches) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. MOD 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included COLECALCIFEROL (VIT D [COLECALCIFEROL]), LISINOPRIL and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 14-Jan-2021 at 4:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2012, the patient experienced HEADACHE (Headache). On 15-Jan-2021, the patient experienced INSOMNIA (not sleeping at night). In January 2021, the patient experienced SWELLING (arm swelled up). On 16-Jan-2021, the patient experienced PYREXIA (fever), CHILLS (chills), PAIN (body aches), ARTHRALGIA (joint aches (hip and neck)) and ASTHENIA (no energy). On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (severe arm pain) and FATIGUE (Tiredness). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. On 15-Jan-2021, HEADACHE (Headache) outcome was unknown. At the time of the report, INSOMNIA (not sleeping at night), PYREXIA (fever), CHILLS (chills), PAIN (body aches), ARTHRALGIA (joint aches (hip and neck)), SWELLING (arm swelled up), PAIN IN EXTREMITY (severe arm pain), ASTHENIA (no energy) and FATIGUE (Tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Body temperature: 100.3 (Inconclusive) 100.3F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Pain, Pain in extremity, Pyrexia
Clinical narrative: severe arm pain; Tiredness; no energy; fever; chills; body aches; joint aches (hip and neck); not sleeping at night; arm swelled up; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), INSOMNIA (not sleeping at night), PYREXIA (fever), CHILLS (chills) and PAIN (body aches) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. MOD 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included COLECALCIFEROL (VIT D [COLECALCIFEROL]), LISINOPRIL and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 14-Jan-2021 at 4:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2012, the patient experienced HEADACHE (Headache). On 15-Jan-2021, the patient experienced INSOMNIA (not sleeping at night). In January 2021, the patient experienced SWELLING (arm swelled up). On 16-Jan-2021, the patient experienced PYREXIA (fever), CHILLS (chills), PAIN (body aches), ARTHRALGIA (joint aches (hip and neck)) and ASTHENIA (no energy). On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (severe arm pain) and FATIGUE (Tiredness). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. On 15-Jan-2021, HEADACHE (Headache) outcome was unknown. At the time of the report, INSOMNIA (not sleeping at night), PYREXIA (fever), CHILLS (chills), PAIN (body aches), ARTHRALGIA (joint aches (hip and neck)), SWELLING (arm swelled up), PAIN IN EXTREMITY (severe arm pain), ASTHENIA (no energy) and FATIGUE (Tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Body temperature: 100.3 (Inconclusive) 100.3F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: severe arm pain; Tiredness; no energy; fever; chills; body aches; joint aches (hip and neck); not sleeping at night; arm swelled up; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), INSOMNIA (not sleeping at night), PYREXIA (fever), CHILLS (chills) and PAIN (body aches) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. MOD 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included COLECALCIFEROL (VIT D [COLECALCIFEROL]), LISINOPRIL and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 14-Jan-2021 at 4:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2012, the patient experienced HEADACHE (Headache). On 15-Jan-2021, the patient experienced INSOMNIA (not sleeping at night). In January 2021, the patient experienced SWELLING (arm swelled up). On 16-Jan-2021, the patient experienced PYREXIA (fever), CHILLS (chills), PAIN (body aches), ARTHRALGIA (joint aches (hip and neck)) and ASTHENIA (no energy). On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (severe arm pain) and FATIGUE (Tiredness). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. On 15-Jan-2021, HEADACHE (Headache) outcome was unknown. At the time of the report, INSOMNIA (not sleeping at night), PYREXIA (fever), CHILLS (chills), PAIN (body aches), ARTHRALGIA (joint aches (hip and neck)), SWELLING (arm swelled up), PAIN IN EXTREMITY (severe arm pain), ASTHENIA (no energy) and FATIGUE (Tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Body temperature: 100.3 (Inconclusive) 100.3F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Headache, Pain in extremity, Pregnancy test
Clinical narrative: Sore arm; Pregnant patient received the Moderna vaccine; Headache; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), EXPOSURE DURING PREGNANCY (Pregnant patient received the Moderna vaccine) and HEADACHE (Headache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergic reaction NOS. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergic reaction NOS, VITAMINS NOS (DAILY MULTIVITAMIN) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 16-Aug-2020 and the estimated date of delivery was 14-May-2021. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), EXPOSURE DURING PREGNANCY (Pregnant patient received the Moderna vaccine) and HEADACHE (Headache). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fifth week of the pregnancy.  On 10-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant patient received the Moderna vaccine) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Sep-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Movement disorder, Muscle tightness, Pain in extremity
Clinical narrative: back pain; muscle tightness in his shoulder; pain in his leg; pain in his arm; he can't move his neck; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), MUSCLE TIGHTNESS (muscle tightness in his shoulder), PAIN IN EXTREMITY (pain in his leg), PAIN IN EXTREMITY (pain in his arm) and MOVEMENT DISORDER (he can't move his neck) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced BACK PAIN (back pain), MUSCLE TIGHTNESS (muscle tightness in his shoulder), PAIN IN EXTREMITY (pain in his leg), PAIN IN EXTREMITY (pain in his arm) and MOVEMENT DISORDER (he can't move his neck). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, BACK PAIN (back pain), MUSCLE TIGHTNESS (muscle tightness in his shoulder), PAIN IN EXTREMITY (pain in his leg), PAIN IN EXTREMITY (pain in his arm) and MOVEMENT DISORDER (he can't move his neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Injection site erythema, Injection site pain
Clinical narrative: weak; extremely tired; chronic headache and after the shot became worse; redness and swollen in the right arm at the injection site; redness and swollen in the right arm at the injection site; soreness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), INJECTION SITE SWELLING (redness and swollen in the right arm at the injection site), INJECTION SITE ERYTHEMA (redness and swollen in the right arm at the injection site), INJECTION SITE PAIN (soreness) and FATIGUE (extremely tired) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PANTOPRAZOLE, GABAPENTIN and CALCIUM for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ASTHENIA (weak), FATIGUE (extremely tired) and HEADACHE (chronic headache and after the shot became worse). In January 2021, the patient experienced INJECTION SITE SWELLING (redness and swollen in the right arm at the injection site), INJECTION SITE ERYTHEMA (redness and swollen in the right arm at the injection site) and INJECTION SITE PAIN (soreness). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. At the time of the report, ASTHENIA (weak), INJECTION SITE SWELLING (redness and swollen in the right arm at the injection site), INJECTION SITE ERYTHEMA (redness and swollen in the right arm at the injection site), INJECTION SITE PAIN (soreness), FATIGUE (extremely tired) and HEADACHE (chronic headache and after the shot became worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications include allergy medication, not otherwise specified.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling
Clinical narrative: weak; extremely tired; chronic headache and after the shot became worse; redness and swollen in the right arm at the injection site; redness and swollen in the right arm at the injection site; soreness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), INJECTION SITE SWELLING (redness and swollen in the right arm at the injection site), INJECTION SITE ERYTHEMA (redness and swollen in the right arm at the injection site), INJECTION SITE PAIN (soreness) and FATIGUE (extremely tired) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PANTOPRAZOLE, GABAPENTIN and CALCIUM for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ASTHENIA (weak), FATIGUE (extremely tired) and HEADACHE (chronic headache and after the shot became worse). In January 2021, the patient experienced INJECTION SITE SWELLING (redness and swollen in the right arm at the injection site), INJECTION SITE ERYTHEMA (redness and swollen in the right arm at the injection site) and INJECTION SITE PAIN (soreness). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. At the time of the report, ASTHENIA (weak), INJECTION SITE SWELLING (redness and swollen in the right arm at the injection site), INJECTION SITE ERYTHEMA (redness and swollen in the right arm at the injection site), INJECTION SITE PAIN (soreness), FATIGUE (extremely tired) and HEADACHE (chronic headache and after the shot became worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications include allergy medication, not otherwise specified.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Arm swollen; Itching; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swollen) and PRURITUS (Itching) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041620A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm swollen) and PRURITUS (Itching). At the time of the report, PERIPHERAL SWELLING (Arm swollen) and PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspepsia, Malaise, Nausea, Vomiting
Clinical narrative: His stomach was upset; Nausea; Vomitting; Diarrhea; Feeling sick; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (His stomach was upset), NAUSEA (Nausea), VOMITING (Vomitting), DIARRHOEA (Diarrhea) and MALAISE (Feeling sick) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced DYSPEPSIA (His stomach was upset), NAUSEA (Nausea), VOMITING (Vomitting), DIARRHOEA (Diarrhea) and MALAISE (Feeling sick). At the time of the report, DYSPEPSIA (His stomach was upset), NAUSEA (Nausea), VOMITING (Vomitting), DIARRHOEA (Diarrhea) and MALAISE (Feeling sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: One finger is really sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (One finger is really sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (One finger is really sore). At the time of the report, PAIN IN EXTREMITY (One finger is really sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea) and HEADACHE (headache). At the time of the report, NAUSEA (Nausea) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Somnolence, Swelling face
Clinical narrative: Swelling in checks/Swelling at the top of the forehead/Puffy cheeks; Lips swelling/Lips are puffy; Sleepy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LIP SWELLING (Lips swelling/Lips are puffy), SWELLING FACE (Swelling in checks/Swelling at the top of the forehead/Puffy cheeks) and SOMNOLENCE (Sleepy) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included FAMOTIDINE for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced SOMNOLENCE (Sleepy). On 20-Jan-2021, the patient experienced LIP SWELLING (Lips swelling/Lips are puffy). On 28-Jan-2021, the patient experienced SWELLING FACE (Swelling in checks/Swelling at the top of the forehead/Puffy cheeks). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, LIP SWELLING (Lips swelling/Lips are puffy), SWELLING FACE (Swelling in checks/Swelling at the top of the forehead/Puffy cheeks) and SOMNOLENCE (Sleepy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Area where the vaccine was administered is sore; Big red circle that is the size of a baseball; Area where the vaccine was administered is itchy; Arm was little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Area where the vaccine was administered is sore), VACCINATION SITE ERYTHEMA (Big red circle that is the size of a baseball), VACCINATION SITE PRURITUS (Area where the vaccine was administered is itchy) and PAIN IN EXTREMITY (Arm was little sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced PAIN IN EXTREMITY (Arm was little sore). On 24-Jan-2021, the patient experienced VACCINATION SITE PAIN (Area where the vaccine was administered is sore), VACCINATION SITE ERYTHEMA (Big red circle that is the size of a baseball) and VACCINATION SITE PRURITUS (Area where the vaccine was administered is itchy). At the time of the report, VACCINATION SITE PAIN (Area where the vaccine was administered is sore), VACCINATION SITE ERYTHEMA (Big red circle that is the size of a baseball), VACCINATION SITE PRURITUS (Area where the vaccine was administered is itchy) and PAIN IN EXTREMITY (Arm was little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and Treatment medications were not provided by reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Muscle discomfort, Myalgia
Clinical narrative: Muscle discomfort; Muscle pain; A spontaneous report was received from a consumer concerning a female patient of unspecified age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced muscle discomfort in both arms and muscle pain (Myalgia).  The patient's medical history was not provided. Concomitant medication was not provided by the reporter.  On an unspecified date in Jan 2021, prior to the onset of the events, the patient received their first of the two planned doses of mRNA-1273 (Lot number: unknown) for prophylaxis of COVID-19 infection.   Post receiving the vaccine, the patient experienced muscle discomfort in both arms. The patient wanted to know if there is anything the patient could take to relief the muscle pain.  Treatment information was not provided by the reporter.   Action taken with mRNA-1273 in response to the events were unknown.   The outcome of the event, muscle discomfort in both arms and muscle pain, were considered unknown on an unknown date.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Skin swelling
Clinical narrative: Bumps all over body; Rash and itching all over body,legs, face and ears; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SKIN SWELLING (Bumps all over body) and RASH PRURITIC (Rash and itching all over body,legs, face and ears) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced SKIN SWELLING (Bumps all over body) and RASH PRURITIC (Rash and itching all over body,legs, face and ears). The patient was treated with CORTISONE at a dose of unknown; ISOPROPANOL (RUBBING ALCOHOL) at a dose of unknwon and PARACETAMOL (TYLENOL) at a dose of unknown. On 27-Jan-2021, SKIN SWELLING (Bumps all over body) and RASH PRURITIC (Rash and itching all over body,legs, face and ears) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling jittery, Pain in extremity, Paraesthesia oral, Pruritus, Rash
Clinical narrative: tingling sensation on tongue; jittery; Skin was prickly on back and arms; Minor red rash and red dots spread out; itchy feeling inside him; rash on both lower legs; arm hurt for 12 hours; A Spontaneous report was received from a consumer concerning a 49 year old, male patient who was participating in the mRNA-1273 Emergency Use Program and experienced several adverse events.  The patient reported, he has allergies to several different things. No relevant concomitant medications were reported.   While participating in this program, the patient experienced the adverse events. The patient received their first of two planned doses of mRNA-1273 on 05 JAN 2021, intramuscularly in the left arm for prophylaxis of COVID-19 infection.    Initially his arm hurt for 12 hours.  On 17Jan2021, 12 days later, he noticed rash on lower legs (patient clarified both legs).  Then 15 days later, he developed itchy feeling inside him. His skin was prickly on back and arms, tingling sensation on tongue. He describes minor red rash, red dots spread out.  He felt jittery, like he had coffee.  Treatment for the event included steroids and cetirizine.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the events were unknown.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Skin irritation
Clinical narrative: tingling sensation on tongue; jittery; Skin was prickly on back and arms; Minor red rash and red dots spread out; itchy feeling inside him; rash on both lower legs; arm hurt for 12 hours; A Spontaneous report was received from a consumer concerning a 49 year old, male patient who was participating in the mRNA-1273 Emergency Use Program and experienced several adverse events.  The patient reported, he has allergies to several different things. No relevant concomitant medications were reported.   While participating in this program, the patient experienced the adverse events. The patient received their first of two planned doses of mRNA-1273 on 05 JAN 2021, intramuscularly in the left arm for prophylaxis of COVID-19 infection.    Initially his arm hurt for 12 hours.  On 17Jan2021, 12 days later, he noticed rash on lower legs (patient clarified both legs).  Then 15 days later, he developed itchy feeling inside him. His skin was prickly on back and arms, tingling sensation on tongue. He describes minor red rash, red dots spread out.  He felt jittery, like he had coffee.  Treatment for the event included steroids and cetirizine.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the events were unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Illness, Malaise, Pyrexia
Clinical narrative: Half sweating to death; sick; Fever; Chills; Extremely ill; A spontaneous report from United States was received from a Consumer concerning a  Years-old male  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced extremely ill, chills, fever, half sweating to death, sick.    The patient's medical history was not provided.  No relevant concomitant medications were reported.    On22-01-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly  for prophylaxis of COVID-19 infection.  On 22-01-2021, The patient experienced extremely ill and chills.  On an unknown date , the patient experienced fever, half sweating to death, sick.  Laboratory details was not provided.   No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache
Clinical narrative: Sore head; Felt a little hot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Felt a little hot) and HEADACHE (Sore head) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced FEELING HOT (Felt a little hot). On 29-Jan-2021, the patient experienced HEADACHE (Sore head). On 29-Jan-2021, FEELING HOT (Felt a little hot) had resolved. At the time of the report, HEADACHE (Sore head) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Additional information received included no new information.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: stiffeness on the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiffeness on the site of injection) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiffeness on the site of injection). At the time of the report, MUSCULOSKELETAL STIFFNESS (stiffeness on the site of injection) outcome was unknown.            Concomitant details not provided.  No treatment information was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus
Clinical narrative: Extreme Itching; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Extreme Itching) and PAIN IN EXTREMITY (Sore Arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 18-Feb-2021, the patient experienced PRURITUS (Extreme Itching). On 14-Feb-2021, PAIN IN EXTREMITY (Sore Arm) had resolved. At the time of the report, PRURITUS (Extreme Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: headache; nausea; fatigue; diarrhea; chills; joint pain; muscle pain; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), CHILLS (chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and VOMITING (vomiting) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031.20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced DIARRHOEA (diarrhea), CHILLS (chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and VOMITING (vomiting). On an unknown date, the patient experienced HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue). On 22-Feb-2021, ARTHRALGIA (joint pain), MYALGIA (muscle pain) and VOMITING (vomiting) had resolved. At the time of the report, DIARRHOEA (diarrhea), CHILLS (chills), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Vomiting
Clinical narrative: headache; nausea; fatigue; diarrhea; chills; joint pain; muscle pain; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), CHILLS (chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and VOMITING (vomiting) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031.20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced DIARRHOEA (diarrhea), CHILLS (chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and VOMITING (vomiting). On an unknown date, the patient experienced HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue). On 22-Feb-2021, ARTHRALGIA (joint pain), MYALGIA (muscle pain) and VOMITING (vomiting) had resolved. At the time of the report, DIARRHOEA (diarrhea), CHILLS (chills), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Nausea, Pain
Clinical narrative: Her arm up to her neck and jaw hurt; Had body aches; Vomiting; Had nausea; She had a headache; Fatigue; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Her arm up to her neck and jaw hurt), PAIN (Had body aches), VOMITING (Vomiting) and NAUSEA (Had nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Patient was tested for COVID positive on Nov 2020.) in November 2020. Concurrent medical conditions included Drug allergy (The patient was allergic to certain blood pressure medication but was unsure of name.), Borderline diabetes and Blood pressure high. Concomitant products included AMLODIPINE, CHLORTHALIDONE, ATORVASTATIN and METFORMIN for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), VOMITING (Vomiting), NAUSEA (Had nausea), HEADACHE (She had a headache) and FATIGUE (Fatigue). On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Her arm up to her neck and jaw hurt) and PAIN (Had body aches). On 20-Feb-2021, DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Her arm up to her neck and jaw hurt), PAIN (Had body aches), VOMITING (Vomiting), NAUSEA (Had nausea), HEADACHE (She had a headache) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vomiting
Clinical narrative: Her arm up to her neck and jaw hurt; Had body aches; Vomiting; Had nausea; She had a headache; Fatigue; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Her arm up to her neck and jaw hurt), PAIN (Had body aches), VOMITING (Vomiting) and NAUSEA (Had nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Patient was tested for COVID positive on Nov 2020.) in November 2020. Concurrent medical conditions included Drug allergy (The patient was allergic to certain blood pressure medication but was unsure of name.), Borderline diabetes and Blood pressure high. Concomitant products included AMLODIPINE, CHLORTHALIDONE, ATORVASTATIN and METFORMIN for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), VOMITING (Vomiting), NAUSEA (Had nausea), HEADACHE (She had a headache) and FATIGUE (Fatigue). On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Her arm up to her neck and jaw hurt) and PAIN (Had body aches). On 20-Feb-2021, DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Her arm up to her neck and jaw hurt), PAIN (Had body aches), VOMITING (Vomiting), NAUSEA (Had nausea), HEADACHE (She had a headache) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Pain in extremity
Clinical narrative: Soreness in left arm,; Tested positive Covid-19; Cough; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive Covid-19), COUGH (Cough) and PAIN IN EXTREMITY (Soreness in left arm,) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced COUGH (Cough). On 24-Jan-2021, the patient experienced COVID-19 (Tested positive Covid-19). On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in left arm,). On 20-Jan-2021, COUGH (Cough) outcome was unknown. At the time of the report, COVID-19 (Tested positive Covid-19) and PAIN IN EXTREMITY (Soreness in left arm,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Numbness in the tongue; Numbness of the face; Headache; Numbness in the arm; A spontaneous report was received from a consumer concerning a 45-years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events numbness in the arm, numbness of the face, numbness in the tongue.  The patient's medical history was not provided. Concomitant medications was not reported.  On 20 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 031L20A) via intramuscular route in his left arm for prophylaxis of COVID-19 infection.  On 20 Feb 2021, the patient experienced the events numbness in the arm, numbness of the face, Headache. On 23 Feb 2021 she experienced event numbness in the tongue. Treatment included ibuprofen was provided by the reporter.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of events, numbness in the arm, numbness of the face, headache, numbness in the tongue were unknown at the time of this report.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Pain, Pyrexia, Vaccination site erythema
Clinical narrative: Swollen Lymph Nodes; Red Swelling Injection Site; Red Swelling Injection Site; Fever; Chills; Body Aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jan-2021 and was forwarded to Moderna on 28-Jan-2021.    This spontaneous case was reported by a dietician and describes the occurrence of PAIN (Body Aches), LYMPHADENOPATHY (Swollen Lymph Nodes), PYREXIA (Fever), CHILLS (Chills) and VACCINATION SITE SWELLING (Red Swelling Injection Site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced PAIN (Body Aches), PYREXIA (Fever) and CHILLS (Chills). On 09-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen Lymph Nodes), VACCINATION SITE SWELLING (Red Swelling Injection Site) and VACCINATION SITE ERYTHEMA (Red Swelling Injection Site). On 30-Dec-2020, PAIN (Body Aches), PYREXIA (Fever) and CHILLS (Chills) had resolved. On 10-Jan-2021, VACCINATION SITE SWELLING (Red Swelling Injection Site) and VACCINATION SITE ERYTHEMA (Red Swelling Injection Site) had resolved. On 11-Jan-2021, LYMPHADENOPATHY (Swollen Lymph Nodes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Swollen Lymph Nodes; Red Swelling Injection Site; Red Swelling Injection Site; Fever; Chills; Body Aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jan-2021 and was forwarded to Moderna on 28-Jan-2021.    This spontaneous case was reported by a dietician and describes the occurrence of PAIN (Body Aches), LYMPHADENOPATHY (Swollen Lymph Nodes), PYREXIA (Fever), CHILLS (Chills) and VACCINATION SITE SWELLING (Red Swelling Injection Site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced PAIN (Body Aches), PYREXIA (Fever) and CHILLS (Chills). On 09-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen Lymph Nodes), VACCINATION SITE SWELLING (Red Swelling Injection Site) and VACCINATION SITE ERYTHEMA (Red Swelling Injection Site). On 30-Dec-2020, PAIN (Body Aches), PYREXIA (Fever) and CHILLS (Chills) had resolved. On 10-Jan-2021, VACCINATION SITE SWELLING (Red Swelling Injection Site) and VACCINATION SITE ERYTHEMA (Red Swelling Injection Site) had resolved. On 11-Jan-2021, LYMPHADENOPATHY (Swollen Lymph Nodes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: rash near and around the site of injection; hard, red, solid, itchy injection site; hard, red, solid, itchy injection site; hard, red, solid, itchy injection site; swelling near around her site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hard, red, solid, itchy injection site), VACCINATION SITE PRURITUS (hard, red, solid, itchy injection site), VACCINATION SITE SWELLING (swelling near around her site of injection), VACCINATION SITE RASH (rash near and around the site of injection) and VACCINATION SITE ERYTHEMA (hard, red, solid, itchy injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE INDURATION (hard, red, solid, itchy injection site), VACCINATION SITE PRURITUS (hard, red, solid, itchy injection site), VACCINATION SITE SWELLING (swelling near around her site of injection) and VACCINATION SITE ERYTHEMA (hard, red, solid, itchy injection site). On an unknown date, the patient experienced VACCINATION SITE RASH (rash near and around the site of injection). At the time of the report, VACCINATION SITE INDURATION (hard, red, solid, itchy injection site), VACCINATION SITE PRURITUS (hard, red, solid, itchy injection site), VACCINATION SITE SWELLING (swelling near around her site of injection), VACCINATION SITE RASH (rash near and around the site of injection) and VACCINATION SITE ERYTHEMA (hard, red, solid, itchy injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medication not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: arm started turning red; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm started turning red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ERYTHEMA (arm started turning red). At the time of the report, ERYTHEMA (arm started turning red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.